Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de James Mullen
Age : 61
Public asset : 3,184,604 USD
Country of residence : Unknown
Linked companies : Thermo Fisher Scientific Inc. - Editas Medicine, Inc.

Biography of James Mullen 
James C. Mullen is a businessperson who has been at the helm of 11 different companies and currently occupies the position of Non-Executive Chairman at Percivia LLC, Chairman, President & Chief Executive Officer of Editas Medicine, Inc. and Chief Executive Officer for DPx Holdings BV. He is also on the board of Thermo Fisher Scientific, Inc. and The Rivers School Corp. and Member of Biomedical Sciences Careers Program, Inc. In the past James C. Mullen occupied the position of Executive Chairman at Vicarius Pharma AG, President, Chief Executive Officer & Director at Biogen, Inc. Director at Biogen Idec, Inc. (North Carolina) and President at Biogen Idec New Ventures, Inc. (both are subsidiaries of Biogen, Inc.), Chairman at Torque Therapeutics, Inc., Chief Executive Officer & Non-Independent Director at Patheon, Inc., Chief Executive Officer & Executive Director at Patheon NV, Principal at GlaxoSmithKline LLC and Chairman for Biotechnology Innovation Organization. He received an MBA from Villanova University and an undergraduate degree from Rensselaer Polytechnic Institute.

Current positions of James Mullen 
Holdings of James Mullen 
James Mullen : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/01RICHARD BRANSON : U.S. aviation agency probes Branson's Virgin Galactic flight deviation
More news

© 2021 People and Ownership :   
James Mullen : Connections 

Latest news about James Mullen 
02/08EDITAS MEDICINE : Chairman to Take on CEO Role
2019Insulet Corporation Announces Board Changes
2018Editas Medicine Appoints James Mullen as its New Chairman of the Board of Directors
More news